Le Lézard
Classified in: Health, Science and technology
Subject: POL

Thumos Care Proposes Market-Friendly Universal Basic Health


NEW YORK, July 29, 2024 /PRNewswire/ -- Thumos Care, a leading AI-powered health optimization platform, today unveiled a proposal for the AI-Enhanced Universal Health and Prevention Act of 2024 (AIUHP Act). This legislation aims to facilitate equitable access to AI-enhanced preventive health services across the United States, leveraging existing healthcare infrastructure and private sector innovation. The proposal aligns closely with recent regulatory focus on AI competition and lifecycle management in healthcare.

Key aspects of the proposed AIUHP Act include:

  1. Facilitation of equitable access to AI-enhanced preventive health services for all U.S. residents, building on existing health insurance coverage.
  2. Support for public-private partnerships to accelerate innovation in AI-enhanced preventive healthcare.
  3. Community implementation support to address health disparities and promote local wellness initiatives.
  4. Robust privacy and data protection measures, addressing the unique challenges posed by AI in healthcare.
  5. Formation of an AI Fairness Board to ensure equitable implementation and prevent algorithmic bias.

Shan Rizvi, co-founder of Thumos Care, stated, "Our proposed Act aligns with the recent Joint Statement by antitrust enforcers on AI competition issues. We're committed to fostering an ecosystem that promotes fair dealing, interoperability, and consumer choice - principles highlighted in the Joint Statement. By facilitating equitable access to innovative tools like Thumos Care, we can potentially save billions in healthcare costs while improving outcomes for all Americans."

The proposed Act is designed to be cost-effective, primarily facilitating the adoption of AI-enhanced health tools rather than creating new government programs. It leverages existing insurance coverage for annual health screenings, minimizing additional costs.

Dr. Maryam Baqir, co-founder of Thumos Care, emphasized the Act's alignment with recent FDA guidelines: "Our proposal incorporates key elements of the FDA's recently published AI Lifecycle Concept. We're particularly focused on robust data management, model validation, and real-world performance evaluation. This Act creates a framework for responsible AI integration in healthcare, ensuring patient safety and ethical practices."

The proposed legislation includes provisions for public-private partnerships to drive innovation and research in AI-enhanced healthcare. It also emphasizes the importance of community-based initiatives and addressing health disparities.

Addressing potential privacy concerns, Rizvi added, "We've taken note of regulators' increased focus on consumer notice and disclosures for AI technologies. Our Act includes strong provisions for transparent communication with users about AI involvement in their healthcare, aligning with emerging policy trends."

The company is currently seeking feedback from healthcare professionals, policymakers, and patient advocacy groups to refine the proposal. Thumos Care invites public discourse on this innovative approach to healthcare and welcomes input from all stakeholders.

For more information about the proposed AI-Enhanced Universal Health and Prevention Act of 2024 and Thumos Care's initiatives, please visit www.thumoscare.com/universal-basic-health.

SOURCE Thumos Care


These press releases may also interest you

at 16:30
Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2024 and provided an update...

at 16:30
K-Bro Linen Inc. (the "Corporation") announced today a dividend of 10.00 cents CDN per common share of the Corporation for the period from December 1 to 31, 2024, to be paid on January 15, 2025 to holders of record of common shares on December 31,...

at 16:20
Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced...

at 16:20
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 98,000 shares of common stock. Awards were made to six new employees of the Company. The...

at 16:05
Kyverna Therapeutics, Inc. (Kyverna), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the recent appointments of Dan Maziasz as Chief Business Officer, Cara Bauer as...

at 15:49
netWelltm, a leading healthcare sharing ministry based in Austin, Texas, is thrilled to announce the expansion of its services to offer members more personalized, accessible, and affordable healthsharing solutions. "These expanded services bring a...



News published on and distributed by: